To our knowledge, prostate cancer is a popular urinary tumor in the elderly of developed countries and disrupted p53 networks is thought to be the major pathways for prostate cancer incidence (Mischitelli et al., 2015). The gene discussed is TP53; the disease is prostate carcinoma.